JPMorgan Chase & Co’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.46K | Sell |
22,782
-859,549
| -97% | -$206K | ﹤0.01% | 5531 |
|
|
2025
Q1 | $174K | Sell |
882,331
-34,610
| -4% | -$6.82K | ﹤0.01% | 4493 |
|
|
2024
Q4 | $494K | Sell |
916,941
-128,592
| -12% | -$69.3K | ﹤0.01% | 4163 |
|
|
2024
Q3 | $994K | Buy |
1,045,533
+8,295
| +0.8% | +$7.88K | ﹤0.01% | 3653 |
|
|
2024
Q2 | $1.01M | Buy |
1,037,238
+122,208
| +13% | +$119K | ﹤0.01% | 3511 |
|
|
2024
Q1 | $1.45M | Sell |
915,030
-13,194
| -1% | -$20.8K | ﹤0.01% | 3346 |
|
|
2023
Q4 | $736K | Sell |
928,224
-103,193
| -10% | -$81.8K | ﹤0.01% | 3700 |
|
|
2023
Q3 | $805K | Sell |
1,031,417
-273,497
| -21% | -$213K | ﹤0.01% | 3512 |
|
|
2023
Q2 | $1.21M | Buy |
1,304,914
+1,071
| +0.1% | +$991 | ﹤0.01% | 3312 |
|
|
2023
Q1 | $1.42M | Buy |
1,303,843
+302,731
| +30% | +$330K | ﹤0.01% | 3248 |
|
|
2022
Q4 | $1.46M | Sell |
1,001,112
-5,720
| -0.6% | -$8.35K | ﹤0.01% | 3160 |
|
|
2022
Q3 | $1.08M | Sell |
1,006,832
-467,331
| -32% | -$503K | ﹤0.01% | 3293 |
|
|
2022
Q2 | $2.51M | Buy |
1,474,163
+74,398
| +5% | +$126K | ﹤0.01% | 2858 |
|
|
2022
Q1 | $2.88M | Sell |
1,399,765
-78,273
| -5% | -$161K | ﹤0.01% | 2941 |
|
|
2021
Q4 | $5.54M | Sell |
1,478,038
-118,223
| -7% | -$443K | ﹤0.01% | 2504 |
|
|
2021
Q3 | $8.25M | Sell |
1,596,261
-260,062
| -14% | -$1.34M | ﹤0.01% | 2204 |
|
|
2021
Q2 | $7.91M | Buy |
1,856,323
+170,603
| +10% | +$727K | ﹤0.01% | 2322 |
|
|
2021
Q1 | $8.95M | Buy |
1,685,720
+656,917
| +64% | +$3.49M | ﹤0.01% | 2211 |
|
|
2020
Q4 | $5.55M | Buy |
1,028,803
+560,490
| +120% | +$3.02M | ﹤0.01% | 2362 |
|
|
2020
Q3 | $3.59M | Sell |
468,313
-31,918
| -6% | -$244K | ﹤0.01% | 2420 |
|
|
2020
Q2 | $5.01M | Buy |
500,231
+403,494
| +417% | +$4.04M | ﹤0.01% | 2153 |
|
|
2020
Q1 | $264K | Buy |
96,737
+20,531
| +27% | +$56K | ﹤0.01% | 3599 |
|
|
2019
Q4 | $91K | Sell |
76,206
-240,623
| -76% | -$287K | ﹤0.01% | 4058 |
|
|
2019
Q3 | $478K | Buy |
316,829
+38,709
| +14% | +$58.4K | ﹤0.01% | 3367 |
|
|
2019
Q2 | $1.11M | Sell |
278,120
-124,234
| -31% | -$496K | ﹤0.01% | 3006 |
|
|
2019
Q1 | $1.73M | Sell |
402,354
-33,924
| -8% | -$146K | ﹤0.01% | 2721 |
|
|
2018
Q4 | $2.51M | Buy |
436,278
+287,753
| +194% | +$1.65M | ﹤0.01% | 2521 |
|
|
2018
Q3 | $2.01M | Sell |
148,525
-63,465
| -30% | -$861K | ﹤0.01% | 2788 |
|
|
2018
Q2 | $2.52M | Buy |
211,990
+26,330
| +14% | +$312K | ﹤0.01% | 2666 |
|
|
2018
Q1 | $2.09M | Buy |
185,660
+164,704
| +786% | +$1.85M | ﹤0.01% | 2729 |
|
|
2017
Q4 | $140K | Buy |
20,956
+11,352
| +118% | +$75.8K | ﹤0.01% | 3783 |
|
|
2017
Q3 | $78K | Buy |
9,604
+3,514
| +58% | +$28.5K | ﹤0.01% | 3705 |
|
|
2017
Q2 | $27K | Sell |
6,090
-14,500
| -70% | -$64.3K | ﹤0.01% | 3864 |
|
|
2017
Q1 | $113K | Sell |
20,590
-13,253
| -39% | -$72.7K | ﹤0.01% | 3681 |
|
|
2016
Q4 | $137K | Buy |
33,843
+12,756
| +60% | +$51.6K | ﹤0.01% | 3781 |
|
|
2016
Q3 | $149K | Buy |
+21,087
| New | +$149K | ﹤0.01% | 3336 |
|